Lilly is a medicine company that puts health above all. Learn about our medicines, view condition support, find care, and much more.

Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries.

2 days ago · Eli Lilly posted fourth-quarter earnings and revenue and 2026 guidance that blew past estimates, as demand for its blockbuster weight loss drug Zepbound and diabetes treatment …

2 days ago · Lilly (LLY) delivered earnings and revenue surprises of +7.88% and +7.95%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

2 days ago · Eli Lilly forecast strong growth for 2026 on Wednesday on the back of surging obesity drug demand, shaking off pricing pressures that helped sink rival Novo Nordisk's outlook.

20 hours ago · Eli Lilly beat earnings soundly yesterday. Today, the stock is selling off on new competition from Hims & Hers Health. Earnings weren't the problem. Lilly beat analyst forecasts for …

1 day ago · Eli Lilly stock surged Wednesday after the drugmaker smashed fourth-quarter expectations on the back of its tirzepatide products.

2 days ago · INDIANAPOLIS, Feb. 4, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its financial results for the fourth-quarter of 2025 and provided 2026 financial guidance.

1 day ago · Lilly is projecting 2026 sales to come in at between $80 billion and $83 billion. The midpoint of the window represents a 25% increase on Lilly's 2025 sales of $65.2 billion.

1 day ago · Eli Lilly’s Q4 beat and bullish 2026 guidance highlight GLP-1 strength from Mounjaro/Zepbound, supporting a $1240–1300 target. Click here to read more.